by pioneering innovative and effective treatments for neurodegenerative diseases,
shaping a healthier future

We transform lives

by pioneering innovative and effective treatments for neurodegenerative diseases, shaping a healthier future

What we do

Pipeline

remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients suffering from age-related neurodegenerative diseases such as Alzheimer’s and Huntington’s disease.

Pipeline

Alzheimer’s program

Aims to provide symptomatic benefit and disease-modification by restoring synaptic function in diseased cells and reducing Aβ and tau pathology over time

Huntington’s program

Restores cortico-striatal transmission by targeting oxidative stress

Discovery program

remynd’s discovery program addresses mitochondrial dysfunction, a hallmark of Amyotrophic Lateral Sclerosis (ALS).

CAREERS

Welcome to our open application page! We are always on the lookout for talented and passionate people to join our team. If you don't see a specific job opening that matches your skills and interests, we encourage you to submit an open application.

ABOUT US

Our mission

We achieve our vision through scientific excellence, rigorous discipline, and a commitment to new approaches. By empowering our people, integrating diverse expertise, fostering strategic partnerships and learning from our peers, we strive to create lasting value for patients, their caregivers and our shareholders

Services

What we offer

Our Contract Research Organization (CRO) helps our clients assess the effects of their experimental Alzheimer and other neurodegenerative disease treatments in our proprietary mouse models. We serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. We have provided pivotal in-vivo proof-of-concept data for several candidate drugs currently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. We have helped our clients to be the first to demonstrate the synergistic effect of a BACE inhibitor and an aBeta antibody, the effect of Tau antibody on aBeta, the effect of donepezil on brain Abeta, …